Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Interaction of Photoprotective and Acclimation Mechanisms in Ulva rigida (Chlorophyta) in Response to Diurnal Changes in Solar Radiation in Southern Chile1.

Cruces E, Rautenberger R, Cubillos VM, Ramírez-Kushel E, Rojas-Lillo Y, Lara C, Montory JA, Gómez I.

J Phycol. 2019 Jun 21. doi: 10.1111/jpy.12894. [Epub ahead of print]

PMID:
31222742
2.

The year's new drugs and biologics 2018: Part II - News that shaped the industry in 2018.

Graul AI, Dulsat C, Pina P, Cruces E, Tracy M.

Drugs Today (Barc). 2019 Feb;55(2):131-160. doi: 10.1358/dot.2019.55.2.2974962. Review.

PMID:
30816887
3.

The year's new drugs and biologics 2018: Part I.

Graul AI, Pina P, Cruces E, Stringer M.

Drugs Today (Barc). 2019 Jan;55(1):35-87. doi: 10.1358/dot.2019.55.1.2959663.

PMID:
30740611
4.

Pulmonary histiocytosis: beyond Langerhans cell histiocytosis related to smoking.

Gallego CT, Bueno J, Cruces E, Stelow EB, Mancheño N, Flors L.

Radiologia. 2019 May - Jun;61(3):215-224. doi: 10.1016/j.rx.2018.11.003. Epub 2019 Jan 24. English, Spanish.

5.

Life sciences licensing deals in the first quarter of 2018: updates and trends.

Cruces E.

Drugs Today (Barc). 2018 Jun;54(6):381-391. doi: 10.1358/dot.2018.54.6.2856494.

PMID:
29998229
6.

Interactive effects of aluminum and cadmium on phenolic compounds, antioxidant enzyme activity and oxidative stress in blueberry (Vaccinium corymbosum L.) plantlets cultivated in vitro.

Manquián-Cerda K, Cruces E, Escudey M, Zúñiga G, Calderón R.

Ecotoxicol Environ Saf. 2018 Apr 15;150:320-326. doi: 10.1016/j.ecoenv.2017.12.050. Epub 2018 Jan 4.

PMID:
29294441
7.

Notable deals in the pharmaceutical industry in the first quarter of 2017.

Cruces E.

Drugs Today (Barc). 2017 Jun;53(6):357-365. doi: 10.1358/dot.2017.53.6.2662982. Review.

PMID:
28799581
8.

Preparation of nanoscale iron (oxide, oxyhydroxides and zero-valent) particles derived from blueberries: Reactivity, characterization and removal mechanism of arsenate.

Manquián-Cerda K, Cruces E, Angélica Rubio M, Reyes C, Arancibia-Miranda N.

Ecotoxicol Environ Saf. 2017 Nov;145:69-77. doi: 10.1016/j.ecoenv.2017.07.004. Epub 2017 Jul 11.

PMID:
28708983
9.

The year's new drugs & biologics 2016: Part II - Trends and highlights of an unforgettable year.

Graul AI, Dulsat C, Tracy M, Cruces E.

Drugs Today (Barc). 2017 Feb;53(2):117-158. doi: 10.1358/dot.2017.53.2.2618153.

PMID:
28387389
10.

The year's new drugs & biologics 2016: Part I.

Graul AI, Pina P, Cruces E, Stringer M.

Drugs Today (Barc). 2017 Jan;53(1):27-74. doi: 10.1358/dot.2017.53.1.2584699. Review.

PMID:
28387385
11.

Notable deals in the pharmaceutical industry in the third quarter of 2016.

Cruces E.

Drugs Today (Barc). 2016 Oct;52(10):569-575.

PMID:
27910965
12.

Notable deals in the pharmaceutical industry in the first quarter of 2016.

Cruces E.

Drugs Today (Barc). 2016 Aug;52(8):453-459.

PMID:
27722213
13.

Physiological acclimation of Lessonia spicata to diurnal changing PAR and UV radiation: differential regulation among down-regulation of photochemistry, ROS scavenging activity and phlorotannins as major photoprotective mechanisms.

Cruces E, Rautenberger R, Rojas-Lillo Y, Cubillos VM, Arancibia-Miranda N, Ramírez-Kushel E, Gómez I.

Photosynth Res. 2017 Feb;131(2):145-157. doi: 10.1007/s11120-016-0304-4. Epub 2016 Sep 12.

PMID:
27620461
14.

Effect of cadmium on phenolic compounds, antioxidant enzyme activity and oxidative stress in blueberry (Vaccinium corymbosum L.) plantlets grown in vitro.

Manquián-Cerda K, Escudey M, Zúñiga G, Arancibia-Miranda N, Molina M, Cruces E.

Ecotoxicol Environ Saf. 2016 Nov;133:316-26. doi: 10.1016/j.ecoenv.2016.07.029. Epub 2016 Jul 30.

PMID:
27485373
15.
16.

The year's new drugs & biologics 2015 - part II:Trends and highlights that marked a complicated year.

Graul AI, Cruces E, Dulsat C, Tracy M.

Drugs Today (Barc). 2016 Feb;52(2):131-63. doi: 10.1358/dot.2016.52.2.2472346.

PMID:
27092342
17.

The year's new drugs & biologics 2015: Part I.

Graul AI, Cruces E, Stringer M.

Drugs Today (Barc). 2016 Jan;52(1):41-89. doi: 10.1358/dot.2016.52.1.2450695. Review.

PMID:
26937494
18.

Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo.

Álvarez G, Martínez J, Varela J, Birriel E, Cruces E, Gabay M, Leal SM, Escobar P, Aguirre-López B, Cabrera N, Tuena de Gómez-Puyou M, Gómez Puyou A, Pérez-Montfort R, Yaluff G, Torres S, Serna E, Vera de Bilbao N, González M, Cerecetto H.

Eur J Med Chem. 2015 Jul 15;100:246-56. doi: 10.1016/j.ejmech.2015.06.018. Epub 2015 Jun 12.

PMID:
26094151
19.

The year's new drugs & biologics 2014 - Part II: trends & challenges.

Graul AI, Serebrov M, Cruces E, Tracy M, Dulsat C.

Drugs Today (Barc). 2015 Feb;51(2):125-52. doi: 10.1358/dot.2015.51.2.2294598. Review.

PMID:
25756068
20.

The year's new drugs & biologics, 2014: Part I.

Graul AI, Cruces E, Stringer M.

Drugs Today (Barc). 2015 Jan;51(1):37-87. doi: 10.1358/dot.2015.51.1.2279964. Review.

PMID:
25685860
21.

Identification of a new amide-containing thiazole as a drug candidate for treatment of Chagas' disease.

Álvarez G, Varela J, Cruces E, Fernández M, Gabay M, Leal SM, Escobar P, Sanabria L, Serna E, Torres S, Figueredo Thiel SJ, Yaluff G, Vera de Bilbao NI, Cerecetto H, González M.

Antimicrob Agents Chemother. 2015 Mar;59(3):1398-404. doi: 10.1128/AAC.03814-14. Epub 2014 Dec 15.

22.

The year's new drugs & biologics, 2013: Part II.

Graul AI, Navarro D, Dulsat C, Cruces E, Tracy M.

Drugs Today (Barc). 2014 Feb;50(2):133-58. doi: 10.1358/dot.2014.50.2.2122810.

PMID:
24619590
23.

The year's new drugs & biologics, 2013: Part I.

Graul AI, Cruces E, Stringer M.

Drugs Today (Barc). 2014 Jan;50(1):51-100. doi: 10.1358/dot.2014.50.1.2116673.

PMID:
24524105
24.

2012 in review - part II: overcoming the obstacles in the pharma/biotech industry.

Rabasseda X, Dulsat C, Navarro D, Cruces E, Graul AI, Jago C, Tracy M.

Drugs Today (Barc). 2013 Feb;49(2):117-43. doi: 10.1358/dot.2013.49.2.1948333. Review.

PMID:
23462626
25.

2012 in review - part I: the year's new drugs & biologics.

Graul AI, Lupone B, Cruces E, Stringer M.

Drugs Today (Barc). 2013 Jan;49(1):33-68. doi: 10.1358/dot.2013.49.1.1933991. Review.

PMID:
23362494
26.

The year's new drugs & biologics, 2011.

Graul AI, Cruces E, Dulsat C, Arias E, Stringer M.

Drugs Today (Barc). 2012 Jan;48(1):33-77. doi: 10.1358/dot.2012.48.1.1769676.

PMID:
22384459
27.

Phlorotannin and antioxidant responses upon short-term exposure to UV radiation and elevated temperature in three south Pacific kelps.

Cruces E, Huovinen P, Gómez I.

Photochem Photobiol. 2012 Jan-Feb;88(1):58-66. doi: 10.1111/j.1751-1097.2011.01013.x. Epub 2011 Nov 10.

PMID:
22011039
28.

The year's new drugs & biologics, 2010.

Graul AI, Cruces E.

Drugs Today (Barc). 2011 Jan;47(1):27-51. doi: 10.1358/dot.2011.47.1.1587820. Review.

PMID:
21373648
29.

Overcoming the obstacles in the pharma/biotech industry: 2009 update.

Graul AI, Revel L, Tell M, Rosa E, Cruces E.

Drug News Perspect. 2010 Jan-Feb;23(1):48-63. doi: 10.1358/dnp.2010.23.1.1437302. Review.

PMID:
20155219
30.

The Year's New Drugs & Biologics - 2009.

Graul AI, Sorbera L, Pina P, Tell M, Cruces E, Rosa E, Stringer M, Castañer R, Revel L.

Drug News Perspect. 2010 Jan-Feb;23(1):7-36. doi: 10.1358/dnp.2010.23.1.1440373. Review.

PMID:
20155217
31.

Overcoming the obstacles in the pharma/biotech industry: 2008 update.

Graul AI, Revel L, Rosa E, Cruces E.

Drug News Perspect. 2009 Jan-Feb;22(1):39-51. doi: 10.1358/dnp.2009.22.1.1303817.

PMID:
19209298
32.

The year's new drugs & biologics - 2008.

Graul AI, Revel L, Barrionuevo M, Cruces E, Rosa E, Verges C, Lupone B, Diaz N, Castaner R.

Drug News Perspect. 2009 Jan-Feb;22(1):7-29. doi: 10.1358/dnp.2009.22.1.1303754.

PMID:
19209296
33.

Overcoming further challenges in the pharma/biotech industry: 2007 update.

Graul AI, Cruces E, Revel L, Serradell N, Rosa E.

Drug News Perspect. 2008 Jan-Feb;21(1):44-58.

PMID:
18301809
34.

The year's new drugs and biologics--2007.

Graul AI, Prous JR, Barrionuevo M, Bozzo J, Castaner R, Cruces E, Revel L, Rosa E, Serradell N, Sorbera LA.

Drug News Perspect. 2008 Jan-Feb;21(1):7-35.

PMID:
18301807
35.

[Analysis of predictive value of Framingham-REGICOR and SCORE functions in primary health care].

Buitrago F, Cañón Barroso L, Díaz Herrera N, Cruces E.

Med Clin (Barc). 2007 Dec 1;129(20):797. Spanish. No abstract available.

PMID:
18093483

Supplemental Content

Loading ...
Support Center